Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The multiplication of analogs, the best strategy for rapid extension of the oncostatic arsenal. How can they be compared experimentally?

× No keyword cloud information.

18 in total

1. A direct measurement of the radiation sensitivity of normal mouse bone marrow cells.

Authors: J E TILL; E A McCULLOCH
Journal: Radiat Res Date: 1961-02 Impact factor: 2.841

2. The oncostatic and immunosuppressive action of new nitrosourea derivatives containing sugar radicals.

Authors: J L Imbach; J L Montero; A Moruzzi; B Serrou; E Chenu; M Hayat; G Mathe
Journal: Biomedicine Date: 1975-12-20

3. Lack of cross-resistance between certain platinum coordination compounds in mouse leukemia.

Authors: J H Burchenal; K Kalaher; T O'Toole; J Chisholm
Journal: Cancer Res Date: 1977-09 Impact factor: 12.701

4. Vindesine international workshop, Frankfurt, Germany, July 7, 1978.

Authors:
Journal: Cancer Chemother Pharmacol Date: 1979 Impact factor: 3.333

5. The growth of mouse bone marrow cells in vitro.

Authors: T R Bradley; D Metcalf
Journal: Aust J Exp Biol Med Sci Date: 1966-06

6. A new antitumoral agent: 9-hydroxyellipticine. Possibility of a rational design of anticancerous drugs in the series of DNA intercalating drugs.

Authors: J B Le Pecq; C Gosse; C Paoletti
Journal: Proc Natl Acad Sci U S A Date: 1974-12 Impact factor: 11.205

7. Pathogen-free isolation unit--three years' experience.

Authors: M Schneider; L Schwarzenberg; J L Amiel; A Cattan; J R Schlumberger; M Hayat; F De Vassal; C Jasmin; C Rosenfeld; G Mathé
Journal: Br Med J Date: 1969-03-29

8. Chlorozotocin, 2-(3-(2-chloroethyl)-3-nitrosoureido)-D-glucopyranose, an antitumor agent with modified bone marrow toxicity.

Authors: T Anderson; M G McMenamin; P S Schein
Journal: Cancer Res Date: 1975-03 Impact factor: 12.701

9. Clinical correlations of drug sensitivity in the human tumor stem cell assay.

Authors: S E Salmon; D S Alberts; B G Durie; F L Meyskens; S E Jones; B Soehnlen; H S Chen; T Moon
Journal: Recent Results Cancer Res Date: 1980

10. Phase II clinical trial with vindesine for remission induction in acute leukemia, blastic crisis of chronic myeloid leukemia, lymphosarcoma, and hodgkin's disease: absence of cross-resistance with vincristine.

Authors: G Mathé; J L Misset; F De Vassal; J Gouveia; M Hayat; D Machover; D Belpomme; J L Pico; L Schwarzenberg; P Ribaud; M Musset; C Jasmin; L De Luca
Journal: Cancer Treat Rep Date: 1978-05

1 in total

1. Cytostatic action of two nitrosoureas derived from cysteamine.

Authors: C Bourut; E Chenu; D Godenèche; J C Madelmont; R Maral; G Mathé; G Meyniel
Journal: Br J Pharmacol Date: 1986-11 Impact factor: 8.739

1 in total